Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126014382 | 12601438 | 2 | F | 20160817 | 20160728 | 20160824 | EXP | US-DRREDDYS-USA/USA/16/0081660 | DR REDDYS | 0.00 | F | Y | 65.77000 | KG | 20160824 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126014382 | 12601438 | 1 | PS | TACROLIMUS. | TACROLIMUS | 1 | Oral | Y | U | UNKNOWN | 90509 | CAPSULE | |||||||
| 126014382 | 12601438 | 2 | SS | TACROLIMUS. | TACROLIMUS | 1 | Oral | Y | U | UNKNOWN | 90509 | 2 | MG | CAPSULE | BID | ||||
| 126014382 | 12601438 | 3 | SS | Duloxetine Delayed-Release Capsules | DULOXETINE | 1 | Unknown | U | UNKNOWN | 90723 | |||||||||
| 126014382 | 12601438 | 4 | C | LYRICA | PREGABALIN | 1 | Oral | 0 | 50 | MG | CAPSULE | TID | |||||||
| 126014382 | 12601438 | 5 | C | LYRICA | PREGABALIN | 1 | Oral | 0 | 75 | MG | CAPSULE | TID | |||||||
| 126014382 | 12601438 | 6 | C | LYRICA | PREGABALIN | 1 | Oral | 0 | 100 | MG | CAPSULE | TID | |||||||
| 126014382 | 12601438 | 7 | C | Centrum Silver 50 plus | 2 | Oral | 0 | 1 | DF | TABLET | QD | ||||||||
| 126014382 | 12601438 | 8 | C | Calcium and Vitamin D | CALCIUMVITAMIN D | 1 | Oral | IN THE MORNING | 0 | 600 | MG | TABLET | QD | ||||||
| 126014382 | 12601438 | 9 | C | fish oil | FISH OIL | 1 | Oral | 0 | 1200 | MG | CAPSULE | QD | |||||||
| 126014382 | 12601438 | 10 | C | fish oil | FISH OIL | 1 | Oral | 0 | 1200 | MG | CAPSULE | BID | |||||||
| 126014382 | 12601438 | 11 | C | SENNA-S | DOCUSATE SODIUMSENNOSIDES | 1 | Oral | 0 | 1 | DF | TABLET | BID | |||||||
| 126014382 | 12601438 | 12 | C | SENNA-S | DOCUSATE SODIUMSENNOSIDES | 1 | Oral | 0 | 1 | DF | TABLET | QD | |||||||
| 126014382 | 12601438 | 13 | C | XANAX | ALPRAZOLAM | 1 | Unknown | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126014382 | 12601438 | 1 | Immunosuppressant drug therapy |
| 126014382 | 12601438 | 3 | Product used for unknown indication |
| 126014382 | 12601438 | 4 | Diabetic neuropathy |
| 126014382 | 12601438 | 7 | Vitamin supplementation |
| 126014382 | 12601438 | 8 | Bone disorder |
| 126014382 | 12601438 | 9 | Blood cholesterol abnormal |
| 126014382 | 12601438 | 11 | Laxative supportive care |
| 126014382 | 12601438 | 13 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126014382 | 12601438 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126014382 | 12601438 | Balance disorder | |
| 126014382 | 12601438 | Irritability | |
| 126014382 | 12601438 | Renal impairment | |
| 126014382 | 12601438 | Tinnitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126014382 | 12601438 | 1 | 201103 | 0 | ||
| 126014382 | 12601438 | 7 | 2011 | 0 | ||
| 126014382 | 12601438 | 9 | 2010 | 0 | ||
| 126014382 | 12601438 | 11 | 2010 | 0 |